EUVIMEDOntdek EUVIMED
Open access · CC BY-NC-ND 4.0

Characteristic miRNA profiles represent clinicopathological diversity of small cell lung cancer

Masafumi Horie, Hiroshi Takumida, Hayato Koba iD, Tsukasa Ueda, Hidenori Tanaka, Masami Suzuki, Yukinobu Ito, Ayumi Ito, Mao Kondo, Hiroshi I Suzuki, Isao Matsumoto, Seiji Yano and 2 more

The Journal of Pathology · 2025

DOI: 10.1002/path.6458 ↗

At a glance

Journal article in The Journal of Pathology, 2025. Written by Masafumi Horie and 13 co-authors. Institution: Division of Molecular and Genomic Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe, Japan. Major MEDLINE topics: MicroRNAs, Lung Neoplasms, Small Cell Lung Carcinoma, Biomarkers, Tumor. Cited 2 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Japan Society for the Promotion of Science, Takeda Science Foundation, Grant for Lung Cancer Research.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Small cell lung cancer (SCLC) is classified into distinct molecular subtypes based on the expression patterns of four transcription regulators: achaete–scute homolog 1 (ASCL1), neuronal differentiation 1 (NEUROD1), POU class 2 homeobox 3 (POU2F3), and yes‐associated protein 1 (YAP1). MicroRNAs (miRNAs) play critical roles in cancer cellular processes but their subtype‐specific implications in SCLC remain underexplored. Out of 46 surgically resected SCLC samples, miRNA visualization through in situ hybridization identified high expression of miR‐375 in the ASCL1, NEUROD1, and ASCL1/NEUROD1 subtypes, and miR‐9‐5p in the POU2F3 subtype. Comprehensive enhancer profiling using SCLC cell lines indicated that miR‐375 and miR‐9‐5p were regulated by super‐enhancers in a subtype‐specific manner. Multiplex immunohistochemistry by imaging mass cytometry found that the miR‐9‐5p‐high SCLC was characterized by a higher stromal area ratio, increased numbers of CD8 + T cells and CD163 − macrophages in the intra‐tumoral area, and an increased number of plasma cells in the stromal area, as compared with the miR‐9‐5p‐low SCLC. Finally, clinicopathological analysis revealed that the miR‐375‐high SCLC was associated with YAP1 downregulation, increased serum pro‐gastrin‐releasing peptide levels, and poor prognosis. These findings highlight the critical role of super‐enhancer‐related miRNAs in the diversity of SCLC, and underscore the potential for novel diagnostic and prognostic biomarkers based on these subtype‐specific miRNAs. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

MicroRNAsLung NeoplasmsSmall Cell Lung CarcinomaBiomarkers, TumorHumansMaleFemaleMiddle AgedGene Expression Regulation, NeoplasticAgedYAP-Signaling ProteinsCell Line, TumorGene Expression ProfilingBasic Helix-Loop-Helix Proteins

Author keywords

SCLCimaging mass cytometrymiRNAmiR‐375miR‐9‐5psuper‐enhancertumor microenvironment

Substances

MicroRNAsBiomarkers, TumorYAP-Signaling ProteinsBasic Helix-Loop-Helix ProteinsMIRN92 microRNA, humanMIRN375 microRNA, humanYAP1 protein, humanASCL1 protein, humanNEUROD1 protein, human

Authors and institutions

  • Division of Molecular and Genomic Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Department of Molecular and Cellular Pathology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
  • Division of Molecular Oncology, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.

ORCID profiles: Hayato Koba

Funding

  • Japan Society for the Promotion of Science
  • Takeda Science Foundation
  • Grant for Lung Cancer Research

Cite

APA

Horie, M., Takumida, H., Koba, H., Ueda, T., Tanaka, H., Suzuki, M., Ito, Y., Ito, A., Kondo, M., Suzuki, H. I., Matsumoto, I., Yano, S., Saito, A., & Maeda, D. (2025). Characteristic miRNA profiles represent clinicopathological diversity of small cell lung cancer. The Journal of Pathology. https://doi.org/10.1002/path.6458

Vancouver

Horie M, Takumida H, Koba H, Ueda T, Tanaka H, Suzuki M, et al. Characteristic miRNA profiles represent clinicopathological diversity of small cell lung cancer. The Journal of Pathology. 2025. doi:10.1002/path.6458

BibTeX
@article{Horie2025,
  author = {Horie, Masafumi and Takumida, Hiroshi and Koba, Hayato and Ueda, Tsukasa and Tanaka, Hidenori and Suzuki, Masami and Ito, Yukinobu and Ito, Ayumi and Kondo, Mao and Suzuki, Hiroshi I and Matsumoto, Isao and Yano, Seiji and Saito, Akira and Maeda, Daichi},
  title = {Characteristic miRNA profiles represent clinicopathological diversity of small cell lung cancer},
  journal = {The Journal of Pathology},
  year = {2025},
  doi = {10.1002/path.6458}
}
Start for free →